Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 October 2007, Vol. 110, No. 8, pp. 3015-3027.
Prepublished online as a Blood First Edition Paper on July 16, 2007; DOI 10.1182/blood-2006-12-061507.


This Article
Right arrow Full Text (PDF)
Right arrow Erratum (v111,p49)
Right arrow All Versions of this Article:
blood-2006-12-061507v1
110/8/3015    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shin, J.
Right arrow Articles by Kupper, T. S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shin, J.
Right arrow Articles by Kupper, T. S
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted December 7, 2006
Accepted June 25, 2007

Lesional gene expression profiling in cutaneous T cell lymphoma reveals natural clusters associated with disease outcome

Jessica Shin, Stefano Monti, Daniel J Aires, Madeleine Duvic, Todd Golub, David A Jones*, and Thomas S Kupper

Department of Dermatology, Brigham and Women's Hospital, Boston, MA, United States
Broad Institute, Massachusetts Institute of Technology, Cambridge, MA, United States
The University of Texas MD Anderson Cancer Center, Houston, TX, United States
Dana-Farber Cancer Institute, Boston, MA, United States
Harvard Medical School, Boston, MA, United States

* Corresponding author; email: dajones{at}partners.org.

Cutaneous T cell lymphoma (CTCL) is defined by infiltration of activated and malignant T cells in skin. The clinical manifestations and prognosis in CTCL are highly variable. In this study, we hypothesized that gene expression analysis in lesional skin biopsies can improve understanding of the disease and its management. Based on 63 skin samples, we performed consensus clustering, revealing three patient clusters. Two clusters tended to differentiate limited CTCL (stages IA and IB) from more extensive CTCL (stages IB and III). Stage IB subjects appeared in both clusters, but those in the limited CTCL cluster were more responsive to treatment than those in the more extensive CTCL cluster. The third cluster was enriched in lymphocyte activation genes and was associated with a high proportion of tumor (stage IIB) lesions. Survival analysis revealed significant differences in event-free survival between clusters, with poorest survival seen in the activated lymphocyte cluster. Using supervised analysis, we further characterized genes significantly associated with lower stage/treatment responsive versus higher stage/treatment resistant CTCL. We conclude that transcriptional profiling of CTCL skin lesions reveals clinically relevant signatures, correlating with differences in survival and response to treatment. Additional prospective long-term studies to validate and refine these findings appear warranted.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arch DermatolHome page
P. Gerami, S. Rosen, T. Kuzel, S. L. Boone, and J. Guitart
Folliculotropic Mycosis Fungoides: An Aggressive Variant of Cutaneous T-Cell Lymphoma
Arch Dermatol, June 1, 2008; 144(6): 738 - 746.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020